Causeway Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $6.91M | Sell |
|
|||||
|
2024
Q3 | $18.2M | Sell |
|
|||||
|
2024
Q2 | $17.5M | Sell |
|
|||||
|
2024
Q1 | $20.1M | Buy |
|
|||||
|
2023
Q4 | $19.2M | Buy |
|
|||||
|
2023
Q3 | $19.2M | Buy |
|
|||||
|
2023
Q2 | $17.6M | Sell |
|
|||||
|
2023
Q1 | $18.6M | Sell |
|
|||||
|
2022
Q4 | $20.7M | Sell |
|
|||||
|
2022
Q3 | $18.6M | Sell |
|
|||||
|
2022
Q2 | $21.2M | Sell |
|
|||||
|
2022
Q1 | $22.9M | Buy |
|
|||||
|
2021
Q4 | $20.6M | Sell |
|
|||||
|
2021
Q3 | $31.2M | Sell |
|
|||||
|
2021
Q2 | $34.2M | Buy |
|
|||||
|
2021
Q1 | $30.6M | Buy |
|
|||||
|
2020
Q4 | $28.1M | Buy |
|
|||||
|
2020
Q3 | $26.4M | Sell |
|
|||||
|
2020
Q2 | $27.6M | Sell |
|
|||||
|
2020
Q1 | $33M | Sell |
|
|||||
|
2019
Q4 | $49.4M | Sell |
|
|||||
|
2019
Q3 | $43.5M | Sell |
|
|||||
|
2019
Q2 | $45.1M | Buy |
|
|||||
|
2019
Q1 | $48.7M | Buy |
|
|||||
|
2018
Q4 | $37.1M | Buy |
|